First Tracks Biotherapeutics Inc (TRAX) Stock Analysis & Investment Frameworks
First Tracks Biotherapeutics Inc (TRAX) stock analysis on Invetso. Review First Tracks Biotherapeutics Inc’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
First Tracks Biotherapeutics Inc Company Overview
- Exchange: NASDAQ Global Select
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
First Tracks Biotherapeutics Inc Key Financial Metrics
- Market Cap: $1.53B
- Revenue: $N/A
- ROE: -53.09%
- ROIC: -77.19%
- Dividend Yield: N/A
About First Tracks Biotherapeutics Inc
First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.